期刊文献+

生脉注射液对2型糖尿病肾病患者血液TNF-α、IL-6的影响 被引量:1

下载PDF
导出
摘要 目的 :观察生脉注射液对 2型糖尿病肾病患者血液细胞因子的影响 ,探讨生脉注射液治疗 2型糖尿病肾病的机制。方法 :采用生脉注射液治疗 2 8例糖尿病肾病患者 ,取常规西药组 2 8例作为对比观察 ,于治疗前后检测患者血液中细胞因子IL 6、TNF α水平。结果 :生脉注射液治疗 2型糖尿病肾病总有效率 75 0 % ,并能显著地降低患者血液中细胞因子的水平。结论 :生脉注射液对 2型糖尿病肾病有显著疗效 ,可能与生脉注射液能调节炎性细胞因子的产生 ,抑制炎症反应有关。
出处 《中原医刊》 2004年第14期2-4,共3页 Central Plains Medical Journal
  • 相关文献

参考文献11

  • 1秦洁,张志利,柳洁.糖尿病肾病发病机制的研究进展[J].山西医科大学学报,2002,33(6):576-578. 被引量:21
  • 2张宏,李晓波.生脉注射液治疗2型糖尿病42例[J].现代中西医结合杂志,2001,10(23):2261-2261. 被引量:1
  • 3李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:253
  • 4Moriwaki Y,Yamamoto T,Shibutani Y,et al.Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2diabetes mellitus: relationship with diabetic nephropathy.Metabolism,2003,52(5 ) :605
  • 5Navarro JF,Mora C,Maca M,et al.Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.J Kidney Dis,2003,42( 1 ) :53
  • 6Ohmori M,Harada K,Kitoh Y,et al.The functions of circulatory polymorphonuclear leukocytes in diabetic patients with and without diabetic triopathy.Life Sci,2000,66(19) :1861
  • 7DiPetrillo K,Coutermarsh B,Gesek FA.Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes.Am J Physiol Renal Physiol,2003,284( 1 ) :F113
  • 8Shikano M,Sobajima H,Yoshikawa H,et al.Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.Nephron,2000,85 ( 1 ) :81
  • 9Ihm CG,Park JK,Kim HJ,et al.Effects of high glucose on interleukin-6production in human mesangial cells.J Korean Med Sci ,2002,17 (2):208
  • 10余上才,增旭东,顾菊英,符胜光.人参皂甙对大鼠单核细胞因子增龄性变化的影响[J].中国中医药科技,2001,8(1):28-29. 被引量:11

二级参考文献27

  • 1杨香媛,韩群,许越香,郑爱华,郭蓓宁,柴淑贞,陈瑾,李国英,李端.Kappa-硒化卡拉胶对阿霉素毒性的预防作用[J].中国药理学通报,1994,10(1):48-50. 被引量:8
  • 2江苏新医学院.中药大辞典(上册),第1版[M].上海:上海科学技术出版社,1985.29-36.
  • 3Schmidt MI, Duncan BB, Scharrct AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet, 1999,353:1649-1652.
  • 4Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 2001,50:2384-2389.
  • 5Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334.
  • 6Festa A, Ralph BD, Russell PT, et al. Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 (PAI-1) predict the development of type 2 diabetes mellitus: the insulin resistance atherosclerosis study (IRAS). Diabetes, 2000,49(Suppl 1):A24-A25.
  • 7Duncan BB, Schmidt MI, Offenbacher S, et al. Factor Ⅷ and other hemostasis variables are related to incident diabetes in adults. Diabetes care, 1999,22:767-772.
  • 8Lindsay RS, Krakoff J, Hanson RL, et al. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes, 2001,50:1598-1603.
  • 9Mcneely MJ, Bokyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care, 1999,22:65-70.
  • 10Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKbeta. Science, 2001,293:1673-1677.

共引文献283

同被引文献15

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部